U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H26N2O2.ClH
Molecular Weight 422.947
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEDIBAZINE HYDROCHLORIDE

SMILES

Cl.C(N1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=C5OCOC5=C4

InChI

InChIKey=BYVBJMSCDWLDRN-UHFFFAOYSA-N
InChI=1S/C25H26N2O2.ClH/c1-3-7-21(8-4-1)25(22-9-5-2-6-10-22)27-15-13-26(14-16-27)18-20-11-12-23-24(17-20)29-19-28-23;/h1-12,17,25H,13-16,18-19H2;1H

HIDE SMILES / InChI

Description

Medibazine (Vialibran) is a piperazine derivative. Medibazine is a coronary vasodilating agent. Although several non-controlled trials report favorable results with angina patients this medication certainly does not provide any outstanding results.

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Inhibitor
8297
PubMed

PubMed

TitleDatePubMed
Angina drug trial: a comparison of the clinical use of vialibran and iproveratril.
1967 Nov 25
[Cardiac anti-arrhythmic effect of various N-substituted piperazine derivatives with respect to aconitine in the rat].
1979
Patents

Patents

US3119826
3
Name Type Language
MEDIBAZINE HYDROCHLORIDE
Common Name English
PIPERAZINE, 1-(1,3-BENZODIOXOL-5-YLMETHYL)-4-(DIPHENYLMETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
CAS
22193-78-8
Created by admin on Fri Dec 15 15:34:56 GMT 2023 , Edited by admin on Fri Dec 15 15:34:56 GMT 2023
PRIMARY
FDA UNII
10F3RUK41T
Created by admin on Fri Dec 15 15:34:56 GMT 2023 , Edited by admin on Fri Dec 15 15:34:56 GMT 2023
PRIMARY
PUBCHEM
23619732
Created by admin on Fri Dec 15 15:34:56 GMT 2023 , Edited by admin on Fri Dec 15 15:34:56 GMT 2023
PRIMARY PUBCHEM
ACTIVE MOIETY
Structure of MEDIBAZINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966